UTHR
United Therapeutics Corporation
NASDAQ: UTHR · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$571.07
+0.34% today
Updated 2026-04-29
Market cap
$25.03B
P/E ratio
20.48
P/S ratio
7.86x
EPS (TTM)
$27.89
Dividend yield
—
52W range
$272 – $608
Volume
0.6M
United Therapeutics Corporation (UTHR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
41.90%
Operating margin
45.20%
ROE
19.70%
ROA
12.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $159.63M | $73.97M | 89.33% | 18.16% | 46.33% |
| 2007 | $210.94M | $19.86M | 89.45% | 2.99% | 9.41% |
| 2008 | $281.50M | $-42.79M | 89.32% | -29.15% | -15.20% |
| 2009 | $369.85M | $19.46M | 87.75% | 7.03% | 5.26% |
| 2010 | $603.83M | $105.92M | 87.83% | 27.16% | 17.54% |
| 2011 | $743.18M | $217.87M | 88.04% | 42.76% | 29.32% |
| 2012 | $916.08M | $304.44M | 86.98% | 46.03% | 33.23% |
| 2013 | $1.12B | $174.56M | 88.26% | 26.19% | 15.63% |
| 2014 | $1.29B | $340.07M | 90.23% | 41.82% | 26.39% |
| 2015 | $1.47B | $651.64M | 95.29% | 47.69% | 44.46% |
| 2016 | $1.60B | $713.70M | 95.45% | 66.41% | 44.64% |
| 2017 | $1.73B | $417.90M | 93.87% | 47.23% | 24.22% |
| 2018 | $1.63B | $589.20M | 87.79% | 49.48% | 36.20% |
| 2019 | $1.45B | $-104.50M | 91.88% | -12.95% | -7.21% |
| 2020 | $1.48B | $514.80M | 92.71% | 40.02% | 34.71% |
| 2021 | $1.69B | $475.80M | 92.73% | 32.98% | 28.23% |
| 2022 | $1.94B | $727.30M | 92.42% | 50.60% | 37.56% |
| 2023 | $2.33B | $984.80M | 88.94% | 50.91% | 42.31% |
| 2024 | $2.88B | $1.20B | 89.24% | 47.86% | 41.53% |
| 2025 | $3.18B | $1.33B | 87.92% | 46.89% | 41.94% |